BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38364970)

  • 1. Pharmacological blockage of NOP receptors decreases ventral tegmental area dopamine neuronal activity through GABA
    Petrella M; Borruto AM; Curti L; Domi A; Domi E; Xu L; Barbier E; Ilari A; Heilig M; Weiss F; Mannaioni G; Masi A; Ciccocioppo R
    Neuropharmacology; 2024 May; 248():109866. PubMed ID: 38364970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic deletion or pharmacological blockade of nociceptin/orphanin FQ receptors in the ventral tegmental area attenuates nicotine-motivated behaviour.
    Domi A; Lunerti V; Petrella M; Domi E; Borruto AM; Ubaldi M; Weiss F; Ciccocioppo R
    Br J Pharmacol; 2022 Jun; 179(11):2647-2658. PubMed ID: 34854073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOP receptor antagonism attenuates reinstatement of alcohol-seeking through modulation of the mesolimbic circuitry in male and female alcohol-preferring rats.
    Borruto AM; Fotio Y; Stopponi S; Petrella M; De Carlo S; Domi A; Ubaldi M; Weiss F; Ciccocioppo R
    Neuropsychopharmacology; 2021 Nov; 46(12):2121-2131. PubMed ID: 34285372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems.
    Norton CS; Neal CR; Kumar S; Akil H; Watson SJ
    J Comp Neurol; 2002 Mar; 444(4):358-68. PubMed ID: 11891648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOP receptor antagonism reduces alcohol drinking in male and female rats through mechanisms involving the central amygdala and ventral tegmental area.
    Borruto AM; Fotio Y; Stopponi S; Brunori G; Petrella M; Caputi FF; Romualdi P; Candeletti S; Narendran R; Rorick-Kehn LM; Ubaldi M; Weiss F; Ciccocioppo R
    Br J Pharmacol; 2020 Apr; 177(7):1525-1537. PubMed ID: 31713848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Modulation of Ventral Tegmental Area Circuits by the Nociceptin/Orphanin FQ System.
    Driscoll JR; Wallace TL; Mansourian KA; Martin WJ; Margolis EB
    eNeuro; 2020; 7(5):. PubMed ID: 32747458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nociceptin/orphanin FQ neurons in the Arcuate Nucleus and Ventral Tegmental Area Act via Nociceptin Opioid Peptide Receptor Signaling to Inhibit Proopiomelanocortin and A
    Hernandez J; Perez L; Soto R; Le N; Gastelum C; Wagner EJ
    Physiol Behav; 2021 Jan; 228():113183. PubMed ID: 32979341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of nociceptin/orphanin FQ-NOP receptor system inhibits tyrosine hydroxylase phosphorylation, dopamine synthesis, and dopamine D(1) receptor signaling in rat nucleus accumbens and dorsal striatum.
    Olianas MC; Dedoni S; Boi M; Onali P
    J Neurochem; 2008 Oct; 107(2):544-56. PubMed ID: 18717817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of δ opioid receptor and blockade of nociceptin/orphanin FQ receptor synergistically attenuate parkinsonism.
    Mabrouk OS; Viaro R; Volta M; Ledonne A; Mercuri N; Morari M
    J Neurosci; 2014 Sep; 34(39):12953-62. PubMed ID: 25253844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands.
    Viaro R; Calcagno M; Marti M; Borrelli E; Morari M
    Neuropharmacology; 2013 Sep; 72():126-38. PubMed ID: 23643745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
    Gavioli EC; Calo' G
    Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.
    Marti M; Mela F; Veronesi C; Guerrini R; Salvadori S; Federici M; Mercuri NB; Rizzi A; Franchi G; Beani L; Bianchi C; Morari M
    J Neurosci; 2004 Jul; 24(30):6659-66. PubMed ID: 15282268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine disinhibits dopamine neurons in the ventral tegmental area via use-dependent blockade of GABA neuron voltage-sensitive sodium channels.
    Steffensen SC; Taylor SR; Horton ML; Barber EN; Lyle LT; Stobbs SH; Allison DW
    Eur J Neurosci; 2008 Nov; 28(10):2028-40. PubMed ID: 19046384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices.
    Chiou LC; Chuang KC; Wichmann J; Adam G
    J Pharmacol Exp Ther; 2004 Nov; 311(2):645-51. PubMed ID: 15254141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray.
    Chiou LC; Fan SH; Chuang KC; Liao YY; Lee SZ
    Ann N Y Acad Sci; 2004 Oct; 1025():398-403. PubMed ID: 15542742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
    Zaveri NT
    Curr Top Med Chem; 2011; 11(9):1151-6. PubMed ID: 21050175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative study of [(pF)Phe4,Arg14,Lys15]nociceptin/orphanin FQ-NH2 (UFP-102) at NOP receptors in rat periaqueductal gray slices.
    Kuo CJ; Liao YY; Guerrini R; Calo' G; Chiou LC
    Eur J Pharmacol; 2008 Jan; 579(1-3):110-5. PubMed ID: 17976580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA(A) receptors in the ventral tegmental area control bidirectional reward signalling between dopaminergic and non-dopaminergic neural motivational systems.
    Laviolette SR; van der Kooy D
    Eur J Neurosci; 2001 Mar; 13(5):1009-15. PubMed ID: 11264674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orphanin FQ/nociceptin suppresses motor activity through an action along the mesoaccumbens axis in rats.
    Narayanan S; Lam H; Carroll FI; Lutfy K
    J Psychiatry Neurosci; 2004 Mar; 29(2):116-23. PubMed ID: 15069465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.